Biotheryx, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer (NCT06515470) | Biotheryx, Inc. | 2024-07-03 |
| A Study of BTX-1188 in Subjects With Advanced Malignancies (NCT05144334) | Biotheryx, Inc. | 2022-01-24 |
Track Biotheryx, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.